Thomas T. Thomas

Thomas T. Thomas, listed as board member, appears in our data through filings on Opiant Pharmaceuticals, Inc. shares, published by SEC (Form 4). We count 31 filings; the first trade dates from 11 May 2018 and the latest from 2 March 2023.

In open-market terms, that means 2 purchases worth €21k on one side and 17 sales worth €190k on the other. The net balance comes to €169k on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 3 share grants and 7 option exercises.

The record was last updated on 3 March 2023 with a transaction (€37k) in Opiant Pharmaceuticals, Inc. The last insider purchase was made public on 8 September 2020, 2,236 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.